Idera investigational agent

· Idera Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Idera investigational agent, covering 2017-11-14 to 2017-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation [Phase 1, Phase 2]